Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Piramal | Healthcare

Pharma Solutions is the contract development and manufacturing (CDMO) division of Piramal | Healthcare, a part of the Piramal Enterprise. We are one of the largest custom manufacturing companies in the world that provides flexibility and scalability of operations. We have created a vast network of contract development and manufacturing facilities located in North America, Europe and Asia that offers a multitude of services that cover the entire drug-cycle, from development and commercial manufacturing to off-patent supplies of Active Pharmaceutical Ingredients (APIs) and formulations. Our network enables us to deliver benefits by strategically placing projects to take advantage of low costs, local supply chains and specific customer/ market requirements. This division features among the top 10 contract drug manufacturers in the world.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Piramal | Healthcare
247 Business Park, A - Wing, 6th Floor, LBS Marg, Vikhroli (West), Mumbai, Maharashtra, 400083, India
022-30956893
Contact Piramal | Healthcare
Website

 Latest Content from PMHub 

Train Your Brain for Success

Videos and Podcasts | December 16, 2021 | Impetus Digital

Max Newlon, President of Brain Co., discusses everything from meditation practices and behavioral science to the use of technology in assessing and treating mental health conditions. He also delves into...

Patient centricity in pharma: musings of a doctor turned medical writer

Press Releases | December 14, 2021 | Porterhouse Medical Group

Elizabeth (Beth) Wynne-Evans, Senior Medical Writer and Medical Advisor at Porterhouse Medical Group, discusses the importance of considering the patient perspective within the pharma industry and healthcare communications

GHO Capital Acquires Genesis Research

Press Releases | December 14, 2021 | Genesis Research Group

GHO Capital Partners LLP, the European specialist investor in global healthcare, announces the acquisition of Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes...

Genesis Research: What is EVID AI?

Press Releases | December 14, 2021 | Genesis Research Group

Genesis Research Announces Significant Enhancements to EVID AI, the World's Largest AI-Enabled Healthcare Literature Database for Faster, More Efficient Searches

Interview with Kate Shaw, Innovative Trials’ Founder/CEO

White Papers and Resources | December 13, 2021 | Innovative Trials

2021 has been a very busy year for Innovative Trials and Kate Shaw discusses the main highlights.

Amplifying Data Science Tools for End-to-End eClinical Solutions

Videos and Podcasts | December 9, 2021 | Impetus Digital

Andreas Weber, Group CEO, EvidentIQ, discusses hybrid vs. fully decentralized trials, the use of real-world evidence (RWE) in clinical trials, and how an end-to-end eClinical solution can help meet increasing...

What is EVID AI?

Videos and Podcasts | December 9, 2021 | Genesis Research Group

Virtual meeting technologies for reducing emissions and waste in the healthcare industry

White Papers and Resources | December 9, 2021 | Impetus Digital

Read the full article here or on the Green Business Bureau blog for more details.

Climbing my own Lucid Ladder

Press Releases | December 7, 2021 | Lucid Group Communications Limited

Transforming lives. That’s what Lucid is all about. I knew that even before I stepped through the fabled door of ‘Towers’ on a chilly January morning in 2019. It’s why...

A Lucid Thirsty Thursday D&I Special

Press Releases | December 3, 2021 | Lucid Group Communications Limited

Last week’s ‘Thirsty Thursday’ session was organised by the Lucid Group D&I Committee, whose goal is to foster a culture where diversity and inclusivity are embedded and practised within all...